ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 91 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $754,630 | -28.0% | 328,100 | -5.1% | 0.00% | 0.0% |
| Q1 2023 | $1,048,077 | +28.0% | 345,900 | -1.6% | 0.00% | 0.0% |
| Q4 2022 | $818,995 | +1.2% | 351,500 | -17.0% | 0.00% | 0.0% |
| Q3 2022 | $809,000 | -29.5% | 423,300 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,147,000 | -16.5% | 423,300 | -8.2% | 0.00% | 0.0% |
| Q1 2022 | $1,374,000 | -24.8% | 461,000 | -1.9% | 0.00% | 0.0% |
| Q4 2021 | $1,828,000 | -14.8% | 470,000 | -6.0% | 0.00% | -50.0% |
| Q3 2021 | $2,145,000 | +41.6% | 500,000 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $1,515,000 | -9.0% | 500,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,665,000 | -6.2% | 500,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,775,000 | +13.4% | 500,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,565,000 | +72.0% | 500,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $910,000 | +55.3% | 500,000 | -13.8% | 0.00% | 0.0% |
| Q1 2020 | $586,000 | -64.9% | 580,100 | -3.3% | 0.00% | 0.0% |
| Q4 2019 | $1,668,000 | -72.9% | 600,000 | -85.2% | 0.00% | -80.0% |
| Q3 2019 | $6,162,000 | -26.7% | 4,040,900 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $8,405,000 | -41.9% | 4,040,900 | 0.0% | 0.01% | -45.5% |
| Q1 2019 | $14,466,000 | -6.5% | 4,040,900 | 0.0% | 0.01% | -15.4% |
| Q4 2018 | $15,477,000 | -59.8% | 4,040,900 | -0.7% | 0.01% | -50.0% |
| Q3 2018 | $38,465,000 | +31.7% | 4,070,400 | +1.7% | 0.03% | +18.2% |
| Q2 2018 | $29,203,000 | +46.0% | 4,000,400 | 0.0% | 0.02% | +46.7% |
| Q1 2018 | $20,002,000 | -1.0% | 4,000,400 | 0.0% | 0.02% | -6.2% |
| Q4 2017 | $20,202,000 | -18.3% | 4,000,400 | +0.3% | 0.02% | -20.0% |
| Q3 2017 | $24,740,000 | +74.0% | 3,990,400 | +1.0% | 0.02% | +66.7% |
| Q2 2017 | $14,221,000 | +11.0% | 3,950,400 | +0.3% | 0.01% | 0.0% |
| Q1 2017 | $12,806,000 | +32.8% | 3,940,400 | +0.1% | 0.01% | +33.3% |
| Q4 2016 | $9,641,000 | -27.6% | 3,935,000 | +1.7% | 0.01% | -30.8% |
| Q3 2016 | $13,312,000 | -0.6% | 3,869,800 | +0.5% | 0.01% | -7.1% |
| Q2 2016 | $13,398,000 | -15.7% | 3,850,000 | 0.0% | 0.01% | -12.5% |
| Q1 2016 | $15,900,000 | +21.9% | 3,850,000 | +31.4% | 0.02% | +23.1% |
| Q4 2015 | $13,043,000 | -24.5% | 2,930,982 | +3.3% | 0.01% | -31.6% |
| Q3 2015 | $17,283,000 | – | 2,838,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |